Nakamura Toshifumi, Hirai Ritsuko, Kitagawa Mutsuo, Takehira Yasunori, Yamada Masami, Tamakoshi Katsutoshi, Kobayashi Yoshimasa, Nakamura Hirotoshi, Kanamori Masao
Department of Gastroenterology, Hamamatsu Medical Center, 328 Tomitsuka-cho, Hamamatsu, Shizuoka, Japan.
Cardiovasc Intervent Radiol. 2002 Sep-Oct;25(5):373-80. doi: 10.1007/s00270-002-0426-2. Epub 2002 May 20.
To compare the effectiveness of various means of stenting in patients with biliary obstruction caused by pancreatic cancer in a retrospective analysis.
Sixty-two patients with biliary obstruction due to unresectable pancreatic cancer underwent biliary stenting. On the basis of the findings obtained by percutaneous transhepatic cholangiography (10 patients) and endoscopic retrograde cholangiography (52 patients), the site of obstruction was distal to the hilar confluence, predominantly especially in the middle to lower third of the common bile duct. Polyurethane-covered Wallstents (9 mm in diameter) were inserted in 13 patients, while uncovered Wallstents (10 mm in diameter) were used in 10 patients and plastic stents (10 Fr and 12 Fr) were used in 39 patients.
Stenting was successful in 34 patients (87.2%) treated with plastic stents and in 22 patients (95.7%) treated with Wallstents. Effective biliary drainage was achieved in 32 out of 34 patients (94.1%) treated with plastic stents and in 21 out of 22 patients (95.5%) treated with Wallstents. The cumulative patency rate was significantly higher for the uncovered and covered Wallstents compared to plastic stents, but was not significantly higher for covered than for uncovered Wallstents. Stent occlusion occurred in 23 patients (70%; all by clogging) from the plastic stent group, in two patients (22%; by tumor ingrowth) from the uncovered Wallstent group, and in one patient (9%; by clogging) from the covered Wallstent group. The survival rate showed no significant difference among the three stent groups.
The Wallstent is effective for long-term palliation in patients with obstruction caused by pancreatic cancer invading the middle to lower part of the common bile duct. The covered Wallstent can prevent tumor ingrowth, a problem with the uncovered Wallstent. However, it may be necessary to take measures to prevent the migration or clogging of covered Wallstents.
通过回顾性分析比较各种支架置入方法对胰腺癌所致胆管梗阻患者的疗效。
62例因无法切除的胰腺癌导致胆管梗阻的患者接受了胆管支架置入术。根据经皮肝穿刺胆管造影(10例患者)和内镜逆行胆管造影(52例患者)的检查结果,梗阻部位位于肝门汇合部远端,主要在胆总管中下段。13例患者置入了直径9mm的聚氨酯覆膜Wallstent支架,10例患者使用了直径10mm的裸Wallstent支架,39例患者使用了塑料支架(10Fr和12Fr)。
使用塑料支架治疗的34例患者中30例(87.2%)支架置入成功,使用Wallstent支架治疗的22例患者中21例(95.7%)成功。使用塑料支架治疗的34例患者中有32例(94.1%)实现了有效的胆汁引流,使用Wallstent支架治疗的22例患者中有21例(95.5%)实现了有效胆汁引流。裸Wallstent支架和覆膜Wallstent支架的累积通畅率显著高于塑料支架,但覆膜Wallstent支架与裸Wallstent支架相比差异无统计学意义。塑料支架组23例患者(70%;均因堵塞)出现支架闭塞,裸Wallstent支架组2例患者(22%;因肿瘤长入)出现支架闭塞,覆膜Wallstent支架组1例患者(9%;因堵塞)出现支架闭塞。三个支架组的生存率差异无统计学意义。
Wallstent支架对胰腺癌侵犯胆总管中下段所致梗阻患者的长期姑息治疗有效。覆膜Wallstent支架可防止肿瘤长入,这是裸Wallstent支架存在的问题。然而,可能有必要采取措施防止覆膜Wallstent支架移位或堵塞。